Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to -$0.01.

  • Mereo BioPharma's EPS (Basic) rose 5000.0% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year change of 0.0%. This contributed to the annual value of -$0.06 for FY2024, which is 4619.92% down from last year.
  • Mereo BioPharma's EPS (Basic) amounted to -$0.01 in Q3 2025, which was up 5000.0% from -$0.02 recorded in Q2 2025.
  • Mereo BioPharma's EPS (Basic)'s 5-year high stood at -$0.01 during Q4 2024, with a 5-year trough of -$0.02 in Q1 2023.
  • For the 3-year period, Mereo BioPharma's EPS (Basic) averaged around -$0.01, with its median value being -$0.01 (2023).
  • The largest annual percentage gain for Mereo BioPharma's EPS (Basic) in the last 5 years was 5000.0% (2024), contrasted with its biggest fall of 10000.0% (2024).
  • Mereo BioPharma's EPS (Basic) (Quarter) stood at -$0.01 in 2023, then rose by 4.74% to -$0.01 in 2024, then decreased by 4.97% to -$0.01 in 2025.
  • Its EPS (Basic) stands at -$0.01 for Q3 2025, versus -$0.02 for Q2 2025 and -$0.02 for Q1 2025.